The Quiet Hero & World Hepatitis Day

Posted by Jesse Gehris on Jul 28, 2019 8:00:00 AM

The largest internal organ in the human body is the liver. The liver aids in digestion, energy storage, removal of toxins from the body, and supports many other functions. Because of the important job requirements set forth for this internal organ, evolution has assured us complete regeneration, so long as 25% of the tissue remaining is healthy.

Read More

Tags: Central Laboratory, Clinical Trial, Drug Development, Bioanalytical Testing, Development, BioPharma, Liver, Hepatitis

Join Eurofins at the 2019 DIA Annual Meeting in San Diego, CA

Posted by Jesse Gehris on Jun 3, 2019 9:15:00 AM

Eurofins BioPharma Services will be attending the DIA Global Annual Meeting in San Diego, CA, June 23-27! Join us at Booth 1705 to discover how our dedicated BioPharma laboratories provide seamless, end-to-end solutions to help customers progress through the drug development cycle through a single, experienced provider!

Read More

Tags: Central Laboratory, Quality, Clinical Trial, Drug Development, Development, BioPharma, Gene Therapy

Eurofins Achieves 2019 CRO Leadership Award

Posted by Jesse Gehris on May 30, 2019 9:00:00 AM

For the 2019 CRO Leadership Awards, Life Science Leader magazine once again teamed up with Industry Standard Research (ISR) to determine the award recipients. More than 60 contract research organizations were assessed on over 20 performance metrics in ISR's annual CRO Quality Benchmarking survey. Eurofins is recognized as a recipient of these awards, exceeding customer expectations in every category.

Read More

Tags: Central Laboratory, Quality, Results, Drug Development, Development, BioPharma

FDA Efforts in Advancing Development of Gene Therapy

Posted by Brian Wile on May 24, 2019 9:25:52 AM

With Dr. Marks’ (Director, Center for Biologics Evaluation and Research), recent perspective on FDA’s Effort to Advance the Development of Gene Therapy, he thoughtfully highlights the recent successes of approved gene therapies, highlights the expert resourcing within FDA, CBER and NIH being applied towards this therapeutic specialization and details the innovative programs and committees (Novel and Exceptional Technology and Research Advisory Committee (NExTRAC), Regenerative Medicine Advanced Therapy (RMAT) designation and the INTERACT program) being instituted and enacted by the FDA.  In addition, he highlights the critical issue facing success of this scientific endeavor, is quality manufacturing capacity but attentively details FDA action of awarding grants dedicated to industry stakeholders for the advancement of manufacturing technologies.

Read More

Tags: FDA, Results, Drug Development, Cellular Response, Development, DNA, Gene Therapy

World Leprosy Day

Posted by Jesse Gehris on Jan 27, 2019 9:00:00 AM

On January 27th,  Eurofins Central Laboratory recognizes World Leprosy Day with the World Health Organization (WHO). Also known as Hansen’s disease, Leprosy is a chronic infectious disease caused by Mycobacterium Leprae. This disease affects the skin, peripheral nerves, mucus membranes of the upper respiratory tract, and eyes. Individuals affected will experience sensory loss in these affected areas as well as damaged thickened nerves.

Read More

Tags: Central Laboratory, Drug Development, Bioanalytical Testing, BioPharma, Leprosy

Antibiotic Resistance Monitoring in Ocular Microorganisms

Posted by Tracy Hendershott on Nov 26, 2018 9:00:00 AM

In the realm of infectious disease, antibiotic resistance is a real and ever increasing concern across the entire healthcare industry.  This is also true for ocular infections.  With bacterial conjunctivitis being the second most common cause (versus viral conjunctivitis), diligent epidemiology and surveillance monitoring brings valued insight to us all.  Eurofins Central Laboratory is proud to have provided analytical services (microbiological species confirmation and antibiotic resistance profile determination) to one of the only two nationwide multi-center surveillance studies (Antibiotic Resistance Monitoring in Ocular Microorganisms - ARMOR) ever undertaken in this indication. Article can be downloaded here.

Read More

Tags: Clinical Trial, Drug Development, Bioanalytical Testing

World COPD Day

Posted by Tracy Hendershott on Nov 21, 2018 9:00:00 AM

World Chronic Obstructive Pulmonary Disease (COPD) Day is organized by the Gloobal Initiative for Chronic Obstructive Lung Disease (GOLD) in collaboration with health care professionals and COPD patient groups throughout the world. World COPD Day is celebrated on November 15th, 2018, and it's aim is to raise awareness about the disease and improve outcomes throughout the world.

Read More

Tags: Central Laboratory, Clinical Trial, Drug Development